Why the study?
Is genetic variation in the lipoprotein lipase (LPL) gene associated with combined hyperlipidemia and altered lipid levels?
Population
Subjects with combined hyperlipidemia and control subjects
Comparison
Lipoprotein lipase gene polymorphism vs Control subjects and different genotypes
Design
Case-control
Authors
Loading...
PvuII LPL variant findings in hyperlipidemia are hypothesis-generating; larger prospective studies needed before any clinical risk stratification.
Is genetic variation in the lipoprotein lipase (LPL) gene associated with combined hyperlipidemia and altered lipid levels?
The PvuII polymorphism of the lipoprotein lipase gene is associated with combined hyperlipidemia and exhibits a gene dosage effect on triglyceride levels.
Hong et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: